These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8589403)

  • 1. [Bacteriopyncnosis--morphological expression of bacterial death in an animal].
    Pal'tsyn AA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Grishina IA; Popova EP
    Biull Eksp Biol Med; 1995 Jun; 119(6):665-8. PubMed ID: 8589403
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cause of benign and malignant courses of infection due to different strains of Pseudomonas aeruginosa].
    Pal'tsyn AA; Tepliakov VG; Chervonskaia NV; Grishina IA; Popova EA
    Biull Eksp Biol Med; 1993 Oct; 116(10):421-4. PubMed ID: 8117973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of generalization of wound infection in immunized rats].
    Pal'tsyn AA; Grishina IA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Popova EP
    Biull Eksp Biol Med; 1994 May; 117(5):545-6. PubMed ID: 9296716
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitization to Pseudomonas aeruginosa in thermal burn patients].
    Kolker II; Minkina AE; Fradkin VA; Panova IuM; Morozov SS
    Klin Med (Mosk); 1982 Jun; 60(6):103-7. PubMed ID: 6811796
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel models for bacterial colonization and infection of full-thickness wounds in rats.
    Asada M; Nakagami G; Minematsu T; Nagase T; Akase T; Huang L; Yoshimura K; Sanada H
    Wound Repair Regen; 2012; 20(4):601-10. PubMed ID: 22642411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
    Zarubina EK; Svetukhin AM; Edvabnaia LS
    Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of antibodies to microorganisms in a focus of purulent inflammation].
    Pal'tsyn AA; Kolokol'chikova EG; Grishina IA; Chervonskaia NV; Badikova AK; Popova EP
    Arkh Patol; 1994; 56(5):15-9. PubMed ID: 7695487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the isolation of an infection-protective antigen from Psudomonas aeruginosa.
    Alexander JW; Brown W; Walker H; Mason AD; Moncrief JA
    Surg Gynecol Obstet; 1966 Nov; 123(5):965-77. PubMed ID: 4959020
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides.
    Pollack M; Tao M; Akiyama M; Pier GB; Koles NL
    Antibiot Chemother (1971); 1991; 44():163-71. PubMed ID: 1801635
    [No Abstract]   [Full Text] [Related]  

  • 10. [Investigation of serum resistance for Pseudomonas aeruginosa and Acinetobacter baumannii strains].
    Cevahir N; Kaleli I; Demir M; Yildirim U; Cevik E; Gürbüz M
    Mikrobiyol Bul; 2006 Jul; 40(3):251-5. PubMed ID: 17001855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Pseudomonas aeruginosa.
    Reynolds P
    Nurs Times; 2000 Jun; 96(23 Suppl):6-8. PubMed ID: 11963422
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of hyperimmune anti-Pseudomonas plasma in the treatment of infectious complications].
    Grishina IA; Terekhova RP; Marchuk AI; Elagina LV; Ostrovskaia EV; Nezhlukto AIa
    Khirurgiia (Mosk); 1990 Nov; (11):121-3. PubMed ID: 2127294
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymph invasion route of bacteria and endotoxin and CD4+/CD8+ T cells ratio changes of draining lymph node of burn infection wound.
    Wang K; Wang DC; Feng YQ; Leng XF
    Burns; 2008 Mar; 34(2):234-40. PubMed ID: 17714877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells are critical for controlling the bacterial burden and the healing of infected wounds.
    Zimmermann C; Troeltzsch D; Giménez-Rivera VA; Galli SJ; Metz M; Maurer M; Siebenhaar F
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20500-20504. PubMed ID: 31548430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
    Wang C; Cai P; Chang D; Mi Z
    J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression.
    Bielecki P; Glik J; Kawecki M; Martins dos Santos VA
    Biotechnol Lett; 2008 May; 30(5):777-90. PubMed ID: 18158583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification and serological typing of Pseudomonas aeruginosa by fluorescent antibody technique.
    Nishimura T; Takagi M; Kotani Y
    Jpn J Exp Med; 1973 Feb; 43(1):43-5. PubMed ID: 4121708
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of Sanoserum P.A. in the treatment of Pseudomonas aeruginosa infection].
    Philips R; Philips I
    Klin Oczna; 1987 Apr; 89(4):158-9. PubMed ID: 3118093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.